ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000203325.3	ABT-263 (navitoclax)	Colon adenocarcinoma	0.045441377	Resistant
ENSG00000203325.3	ABT-263 (navitoclax)	Brain lower grade glioma	0.031880482	Resistant